Skip to content

Developing and Pilot Testing a Remote Smoking Cessation Digital Therapeutic for Individuals With Serious Mental Illness

Developing and Pilot Testing a Remote Smoking Cessation Digital Therapeutic for Individuals With Serious Mental Illness

Status
Withdrawn
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05031416
Enrollment
0
Registered
2021-09-01
Start date
2025-06-30
Completion date
2025-12-31
Last updated
2025-04-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Smoking Cessation

Brief summary

This is a pilot randomized clinical trial testing an implementation intervention to support delivery of a smoking cessation app tailored to the needs of those individuals with SMI who at community mental health programs.

Detailed description

Learn to Quit (LTQ), an evidence-based smoking cessation app tailored to the needs of individuals with serious mental illness (SMI) that demonstrated promising smoking cessation outcomes in a recent pilot randomized controlled trial (R00 DA037276). In parallel, several trials demonstrated that widely available social media platforms can be effectively utilized to enhance the effects of standard of care evidence-based smoking cessation treatments. Both approaches capitalize on highly scalable digital technologies, and are therefore likely to have population level impact. Drawing from these two separate programs of research, the central premise of this proposal is that LTQ, a stand-alone smoking cessation app tailored to patients with SMI, can be enhanced with peer-support delivered on social media. Therefore, this proposal seeks to develop and asses the acceptability and feasibility of LTQ-Connect -- the integration of the evidence-based smoking cessation app, LTQ, with social support delivered via social media -- to boost the efficacy and community reach of digital therapeutics tailored for patients with SMI. To achieve this goal, we will: (1) determine the ideal design requirements of an LTQ-Connect integration among smokers with SMI, and (2) investigate the feasibility of LTQ-Connect in a single group pilot trial. Both interventions will be combined with nicotine replacement therapy, a safe and widely available medication.

Interventions

COMBINATION_PRODUCTLTQ

The investigators will test the LTQ-Connect application and a standard 10-week course of nicotine replacement therapy (NRT) nicotine patches, and Facebook groups, which will run for a total of 3 months with research study participants

Sponsors

National Institute of Mental Health (NIMH)
CollaboratorNIH
Johns Hopkins University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Must be a mental health consumer at Johns Hopkins Bayview Adult Psychiatry Program * A regular smoker who is willing to quit * Own a smart cell phone * Willing to participate

Exclusion criteria

* Women who report being pregnant or have the intention to become pregnant in the 3 months

Design outcomes

Primary

MeasureTime frameDescription
User Engagement with Facebook groups - Content13 weeksThe Facebook API will be used to extract engagement content of Facebook posts, comments, and 'likes.'
User Engagement with Facebook groups - Comments13 weeksThe Facebook application programming interface (API) will be used to extract number of Facebook comments.
User Engagement with Facebook groups - Likes13 weeksThe Facebook API will be used to extract number of Facebook likes.
User Engagement with Facebook groups - Posts13 weeksThe Facebook API will be used to extract number of Facebook posts.
Change in Self reported social support13 weeksAn adapted version of Online Social Support (OSS) scale for smokers will be used to evaluate self-reported social support from online smoking cessation treatment (LTQapp + Facebook group) The OSS scale is a 14 item scale with choices - 1 disagree a lot, to 4 agree a lot. Scale range 14- 56 with higher score indicating better outcome.
App Usability13 weeksThe System Usability Scale (SUS) is a 10-item scale used to evaluate usability of the LTQ-Connect app. Choices range from 1 strongly disagree, to 5 Strongly agree. Scale range 10-50 with higher score indicating more agreement.
Number of user Interactions with the Learn to Quit (LTQ) app13 weeksGoogle Analytics will be used to extract number of daily app interactions and duration of engagement with LTQ app.
Duration of user Interactions with the Learn to Quit (LTQ) app13 weeksGoogle Analytics will be used to extract daily duration of interactions with LTQ app in minutes.

Secondary

MeasureTime frameDescription
Psychiatric FunctioningWeek 5, Week 9, and Week 13The Brief Symptom Inventory (BSI) assesses distress participants are experiencing. The BSI is a 13 item scale with choices 0=not at all, to 4= Extremely. A higher score indicates more distress. Score range 0-52.
Change in number of cigarettes smoked per dayWeek 5, Week 9, and Week 13The Smoking timeline follow-back (TLFB) will be used to estimate the number of cigarettes per day

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026